DEPYMED
Company Overview
Industries
Social Media Profiles
About DepYmed
Description
DepYmed is a biotechnology company focused on developing innovative PTP1B inhibitors for therapeutic applications in diseases such as Rett Syndrome, Wilson Disease, and cancer. By targeting the PTP1B enzyme, DepYmed aims to create effective treatments for rare and metabolic diseases.
Specialties
PTP1B enzyme inhibitors
Therapeutics for rare diseases
Innovative cancer treatments
Metabolic disease applications
CNS and cardiovascular focus
Products & Services
PTP1B Inhibitors
Cancer Therapies
Rett Syndrome Treatments
Wilson Disease Treatments
Metabolic Disease Solutions
Contact Information
No contact information available
Competitors & Similar Companies(10)
Alnylam Pharmaceuticals
Massachusetts, • United States
Ionis Pharmaceuticals
Sarepta Therapeutics
Regeneron Pharmaceuticals
New York, • United States
Blueprint Medicines
Massachusetts, • United States
Amicus Therapeutics
New Jersey, • United States
Catalyst Pharmaceuticals
Florida, • United States
AveXis
Vertex Pharmaceuticals
Massachusetts, • United States
Ultragenyx Pharmaceutical
California, • United States
News & Media
Search Terms:
depymed
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about DepYmed
Where is DepYmed located?
The headquarter of DepYmed is located in Farmingdale, New York, United States
What is the official website of DepYmed?
The official website of DepYmed is https://www.depymedinc.com
What industry does DepYmed belong to?
DepYmed belongs to the Pharmaceuticals industry.
What are the specialties of DepYmed?
DepYmed specializes in PTP1B enzyme inhibitors, Therapeutics for rare diseases, Innovative cancer treatments, Metabolic disease applications, CNS and cardiovascular focus.
What products and services is DepYmed likely to offer?
DepYmed offers PTP1B Inhibitors, Cancer Therapies, Rett Syndrome Treatments, Wilson Disease Treatments, Metabolic Disease Solutions.
Who are the competitors of DepYmed?
Competitors of DepYmed are Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Sarepta Therapeutics, Regeneron Pharmaceuticals, Blueprint Medicines, Amicus Therapeutics, Catalyst Pharmaceuticals, AveXis, Vertex Pharmaceuticals, Ultragenyx Pharmaceutical.
What does DepYmed do?
DepYmed is a biotechnology company focused on developing innovative PTP1B inhibitors for therapeutic applications in diseases such as Rett Syndrome, Wilson Disease, and cancer. By targeting the PTP1B enzyme, DepYmed aims to create effective treatments for rare and metabolic diseases.
What are the social media links of DepYmed?
Social media links of DepYmed are